Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Oct 2026 for Royalty Pharma plc, €210k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Urist Marshall: trading record in brief
All filings by Urist Marshall on record concern Royalty Pharma plc. In total, 4 filings cover trades dated from 24 June 2026 to 5 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 5 October 2026 with a transaction (€210k) in Royalty Pharma plc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Urist Marshall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
4,126 shares@ US$57.10Common StockSEC144:0001964306-26-000465
4,126 shares@ US$57.880.0007% mcap1.7% of flowCommon StockSEC144:0001964306-26-000456
9,099 shares@ US$55.88020.0015% mcap3.6% of flowCommon StockSEC144:0001964306-26-000306
9,098 shares@ US$55.18430.0016% mcap3.5% of flowCommon StockSEC144:0001964306-26-000296
4 of 4 declarations
